"Why isn't this molecule working?"
Toma tilted his head looking at the experimental results.
Rei asked. "Which enzyme did you use?"
"Hexokinase. But when I tried mannose, no reaction."
Kana asked. "What's mannose?"
"A sugar very similar to glucose," Toma answered.
Rei drew structural formulas in his notebook. "Almost identical. But stereochemistry at position 2 is different."
"Just that?"
"Substrate specificity. Enzymes recognize only specific substrates."
Toma murmured. "But the shapes are almost the same."
"The active site is extremely precise," Rei explained. "Even slight differences can't be recognized."
Kana took notes. "Lock and key?"
"Yes. But it's not perfectly fixed."
"Then close shapes can enter?"
Rei nodded. "Let's try. A competitive inhibition experiment."
Toma prepared another test tube. "Mix glucose and mannose?"
"Yes. Both compete for the active site."
Kana observed. "The reaction slowed down."
"Mannose is entering the active site," Rei explained.
"But no reaction?"
"Can't. Doesn't achieve the correct configuration."
Toma took notes. "Substrate gets lost."
"And interferes with the real substrate."
Kana asked. "How does it distinguish?"
Rei drew a diagram. "Active site amino acids interact with specific atoms of the substrate."
"Hydrogen bonds?"
"That too. Van der Waals forces, electrostatic interactions."
Toma continued. "With mannose, that configuration shifts?"
"Exactly. When the OH at position 2 faces the opposite direction, hydrogen bonds can't form."
Kana understood. "So it's not recognized."
"But not completely excluded. Binds weakly."
Rei continued. "This is the principle of competitive inhibitors."
"Inhibitors?" Toma asked.
"Molecules similar to substrate that inhibit the enzyme."
Kana took notes. "Drugs?"
"Many drugs use this principle."
Rei gave an example. "Methotrexate. Similar to folic acid but inhibits the enzyme."
Toma asked. "And that cures disease?"
"Suppresses cancer cell proliferation. By inhibiting folate metabolism."
Kana thought. "But normal cells too?"
"Yes. That's why there are side effects. Selectivity is important."
Rei continued. "Exploiting subtle differences in enzyme substrate specificity."
Toma summarized in his notebook. "The moment substrate gets lost, there's also therapeutic potential."
"But also danger," Rei warned.
"What do you mean?"
"Unintended inhibition. Drug interactions."
Kana took notes. "One drug interferes with another metabolic pathway?"
"Yes. CYP enzyme inhibition is a typical example."
Toma asked. "CYP?"
"Cytochrome P450. Drug-metabolizing enzyme."
Rei explained. "Grapefruit interacting with certain drugs is also CYP inhibition."
Kana was surprised. "Even with food?"
"Flavonoids inhibit the enzyme."
Toma murmured. "Molecular recognition is complex."
"That's what makes it interesting," Rei smiled.
Kana asked. "Is there perfect specificity?"
"No. Always a tradeoff. Specificity versus efficiency."
Toma took notes. "Life chose moderate precision."
"Yes. Too perfect leaves no room for evolution."
Kana murmured. "Room for substrates to get lost creates diversity."
Rei acknowledged. "Errors sometimes generate new functions."
The three fell silent. The moment substrate gets lost, chemistry becomes biology.